US 9920297
Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1
granted A61KA61K2035/11A61K2039/523
Quick answer
US patent 9920297 (Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1) held by Vaximm AG expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vaximm AG
- Grant date
- Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2035/11, A61K2039/523, A61K35/74, A61K39/00